- Home
- TVRD vs MVT Comparison
TVRD vs MVT Comparison
Compare TVRD & MVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TVRD
- MVT
- Stock Information
- Founded
- TVRD 2017
- MVT 1993
- Country
- TVRD United States
- MVT United States
- Employees
- TVRD N/A
- MVT N/A
- Industry
- TVRD Biotechnology: Pharmaceutical Preparations
- MVT Investment Bankers/Brokers/Service
- Sector
- TVRD Health Care
- MVT Finance
- Exchange
- TVRD Nasdaq
- MVT Nasdaq
- Market Cap
- TVRD 246.5M
- MVT 214.7M
- IPO Year
- TVRD N/A
- MVT N/A
- Fundamental
- Price
- TVRD $29.44
- MVT $10.16
- Analyst Decision
- TVRD Strong Buy
- MVT
- Analyst Count
- TVRD 5
- MVT 0
- Target Price
- TVRD $59.20
- MVT N/A
- AVG Volume (30 Days)
- TVRD 93.5K
- MVT 49.7K
- Earning Date
- TVRD 08-21-2025
- MVT 01-01-0001
- Dividend Yield
- TVRD N/A
- MVT 4.15%
- EPS Growth
- TVRD N/A
- MVT N/A
- EPS
- TVRD N/A
- MVT N/A
- Revenue
- TVRD N/A
- MVT N/A
- Revenue This Year
- TVRD N/A
- MVT N/A
- Revenue Next Year
- TVRD N/A
- MVT N/A
- P/E Ratio
- TVRD N/A
- MVT N/A
- Revenue Growth
- TVRD N/A
- MVT N/A
- 52 Week Low
- TVRD $8.13
- MVT $8.96
- 52 Week High
- TVRD $34.31
- MVT $11.17
- Technical
- Relative Strength Index (RSI)
- TVRD N/A
- MVT 45.65
- Support Level
- TVRD N/A
- MVT $10.18
- Resistance Level
- TVRD N/A
- MVT $10.33
- Average True Range (ATR)
- TVRD 0.00
- MVT 0.12
- MACD
- TVRD 0.00
- MVT -0.00
- Stochastic Oscillator
- TVRD 0.00
- MVT 27.59
About TVRD Tvardi Therapeutics Inc. Common Stock
Tvardi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases. Its key product candidate, TTI-101, is in Phase 2 clinical development for the treatment of idiopathic pulmonary fibrosis (IPF), and hepatocellular carcinoma (HCC). Its second product candidate, TTI-109, is structurally related to, yet chemically distinct from, TTI-101 and is designed to enhance the ability to target STAT3.
About MVT Blackrock MuniVest Fund II Inc.
Blackrock Munivest Fund II Inc is a closed-end management investment company. The fund's objective is to provide shareholders with as high a level of current income exempt from U.S. federal income taxes as is consistent with its investment policies and prudent investment management. The company invests in Transportation, Health, Utilities, Education, Housing, and other sectors.